Live
- NASA Tracks Five Giant Asteroids on Close Approach to Earth Today
- Pushpa 2 Hits ₹1000 Crore in 6 Days: How It Compares to Other Top Indian Films
- Vivo X200 and X200 Pro Launched in India: Price, Specifications, and Features
- Nitin Gadkari Admits Feeling Embarrassed at Global Summits Over Rising Road Accidents in India
- Comprehensive Review on Indiramma Housing Survey and Welfare Initiatives Conducted via Video Conference
- Jogulamba Temple Records Rs 1.06 Crore Hundi Revenue in 150 Days
- Opposition Slams ‘One Nation, One Election’ Bill as Anti-Democratic; BJP Allies Support the Move
- Celebrate Karthigai Maha Deepam Virtually with Sri Mandir’s LIVE Darshan Experience
- BJP Extends Support to Samagra Shiksha Abhiyan Employees' Strike, Demands Immediate Regularization and Welfare Benefits
- Dr. M. Priyanka Stresses Quality Education, Nutritious Meals, and Cleanliness in Schools
Guv launches portal for Hepatitis C patients
Governor E S L Narasimhan launched the Asian Institute of Gastroenterology’s portal for Hepatitis C patients at Taj Krishna on Monday. Speaking on the occasion, he said the portal would help create awareness about the disease by providing a platform for patients to interact with medical experts.
Hyderabad: Governor E S L Narasimhan launched the Asian Institute of Gastroenterology’s portal for Hepatitis C patients at Taj Krishna on Monday. Speaking on the occasion, he said the portal would help create awareness about the disease by providing a platform for patients to interact with medical experts. “India needs a healthy population. The Indian pharma industries are heading close to achieving merit in healthcare.
The portal will aim to cater to all the four components of healthcare, i.e. awareness, availability, accessibility and affordability,” Narasimhan said. Speaking about the disease, Dr Nageshwar Reddy, Chairman of Asian Institute of Gastroenterology said Hepatitis C was a matter of grave concern in India with 50 million people suffering from the disease.
He further added that a recent discovery of direct acting anti-viral drug cures Hepatitis C in 98 per cent of the cases, but was not affordable and costs close to one crore rupees. He said an initiative by Indian pharma industries has cut down the cost of medication to Rs 60,000. “The portal launched will help patients to get information on the disease and its treatment,” said the doctor.
